Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 902-904, Vol. 38, No. 2
Departments of Medicine, The University of
Texas Health Science Center at San Antonio,1 and
Audie Murphy Division, South Texas Veterans Health Care
System,2 San Antonio, Texas 78284
Received 17 August 1999/Returned for modification 28 September
1999/Accepted 15 November 1999
Seven isolates each of Candida albicans and
Candida dubliniensis were paired (11 pairs) and examined
for competitive interaction. Equal numbers of CFU of each competitor
were inoculated into Sabouraud dextrose broth and incubated at 37°C
with vigorous shaking under conditions favorable to either broth or
biofilm growth. Surviving proportions of each competitor were
calculated from the broth culture at 24 and 96 h and the biofilm
culture at 96 h, with species differentiation done on CHROMagar
Candida medium. C. albicans had a competitive advantage
over C. dubliniensis in broth culture and under biofilm
growing conditions; however, with the presence of a supporting
structure for biofilm formation, C. dubliniensis was able
to better withstand the competitive pressures from C. albicans.
Candida dubliniensis is
an opportunistic yeast with remarkable phenotypic similarity to
Candida albicans (13, 16). C. dubliniensis has been implicated in oropharyngeal candidiasis (OPC) in human immunodeficiency virus (HIV)-infected individuals and
has been recovered from the oral cavities of HIV-negative individuals
(13, 27, 28). While C. albicans is generally considered to be the most pathogenic of the Candida species,
a variety of other members of this genus, notably C. krusei,
C. glabrata, C. tropicalis, and C. dubliniensis, have been cited as the causative agents of an
increasing number of infections (10, 16, 26). Causes for
this recent epidemiological deviation toward less pathogenic yeasts in
oral infections remain unclear (29). Some evidence suggests
that the increased use of fluconazole or other antifungal agents may be
responsible for the emergence of yeasts with decreased antifungal
susceptibility, and this may, in turn, alter the epidemiology of OPC
(16, 17). A number of other risk factors, such as the use of
broad-spectrum antibacterial antibiotics, surgical procedures, and
immunosuppression related to organ transplant, have also been
implicated in this epidemiological shift (1).
Oropharyngeal candidiasis is a notable cause of morbidity among
HIV-infected and AIDS patients (24). Other forms of mucosal candidiasis are frequently found in other patient groups, such as
denture wearers, infants, the elderly, and recent recipients of
antibiotic therapy (6). One of the first steps in the
development of infection is the adherence of yeasts to host tissues or
prosthetic devices (20, 25). Several Candida
species, including C. albicans, C. krusei,
C. glabrata, and C. tropicalis, have demonstrated
the potential to colonize plastic surfaces (19, 20, 25, 30). Factors known to have an effect on the retention or distribution of
oral Candida species are many. Acidic pH, sucrose- or
glucose-rich diets, and Candida cell surface mannoprotein
and cell surface hydrophobicity all tend to enhance adhesion (14,
15, 30), yet the complex subject of candidal adhesion and
colonization remains poorly understood (5, 19, 30).
The mouth is diverse as a microbial habitat. It contains soft mucosal
tissues as well as hard tissues (teeth) and junctures between them;
each of these, being warm, moist, and bathed in nutrients, provides an
environment suitable for the proliferation of mixed-species
colonization (9, 15). A variety of factors, such as changes
in pH, nutrient availability, and temperature, may lead to changes in
the microbial balance (4). In bacteria, one means of
survival available to many oral species is the ability to form
biofilms, which confers, in some measure, resistance to antibiotics and
host defenses (1, 9). In this regard, adherent (sessile)
cells may display properties different from those of their free-living
(planktonic) counterparts (7, 11, 12). In nature, most
microorganisms do not exist as pure cultures of free-living cells but
are associated with surfaces and multispecies consortia (7).
In suspension cultures of bacteria, where the constituent
microorganisms all experience exposure to a common environment, a
single phenotype tends to predominate (9). In biofilms, the
situation is more diverse. The complex structure of the biofilm allows
stratification into spatially organized populations of mixed-species
communities, where some degree of interspecies cooperation develops
(4, 7, 9).
While previous studies of biofilm development and species interaction
have focused largely on bacterial species, the present experiments
highlight interactions between two similar yeasts, C. dubliniensis and C. albicans. Competition growth assays
were performed using several pairs of these two yeasts, grown under conditions favoring the growth of either free-living cells or biofilms.
Sabouraud liquid broth modified antibiotic medium 13 (SDB) (BBL,
Cockeysville, Md.) was prepared from a powdered medium according to the
manufacturer's instructions. The solution was dissolved, dispensed in
4-ml volumes into 18- by 150-mm culture tubes, and autoclaved. An
additional set of tubes was prepared as described above, but each
contained a single 1-cm piece of polyvinyl chloride (PVC) "feeding
tube and urethral catheter" (Monoject, St. Louis, Mo.). The tubes of
medium were cooled, stored at 4°C, and used within 1 week.
Clinical samples were obtained from HIV-infected patients enrolled in a
longitudinal study of OPC at the University of Texas Health Science
Center at San Antonio and the South Texas Veterans Health Care System,
Audie L. Murphy Division, San Antonio (23, 24). These
patients had advanced AIDS with mean CD4 cell counts of
<50/mm3. Samples were obtained weekly during therapy and
quarterly as surveillance cultures by having patients swish and spit 10 ml of normal saline to be used for culturing (21, 24). One
hundred microliters of the swish solution was plated on media with and without fluconazole at concentrations of 8 and 16 µg/ml and incubated at 30°C for 48 h before growth was assessed. CHROMagar Candida (CHROMagar Company, Paris, France) with fluconazole was used to improve
detection of non-C. albicans species and resistant isolates (21). Growth assessment was recorded and three to five yeast colonies from each culture were stored on Sabouraud dextrose slants (BBL) at Clinical samples were submitted to the Fungus Testing Lab (the
University of Texas Health Science Center) for MIC determination by
both the National Committee for Clinical Laboratory Standards broth
macrodilution procedure (18) and broth microdilution
adaptation (2, 8, 18).
Competition growth assays were performed in duplicate with pairs of
clinical isolates of C. albicans and C. dubliniensis. Seven clinical samples each of C. albicans and C. dubliniensis were selected to represent
both fluconazole susceptibility and resistance and have previously been
described in more detail (13, 14). Yeast isolates, stored at
room temperature in sterile deionized H2O, were subcultured
onto Sabouraud dextrose agar to ensure purity and viability
(3) and then subcultured again to select for isolated
colonies. Each competitor of the pair was inoculated at 5 × 105 CFU (total of 106 CFU) into 4 ml of SDB
alone and into 4 ml of SDB containing a single 1-cm piece of PVC
feeding tube and urethral catheter and incubated at 37°C with
vigorous shaking. Daily transfers of 100 µl of resultant broth
culture or gently washed catheter section into fresh medium were
performed. Surviving proportions of each competitor were calculated
from the broth culture at 24 and 96 h with species differentiation
done on CHROMagar Candida medium. Proportions of each competitor were
obtained from the piece of PVC at 96 h, after the PVC piece had
been washed and then vigorously vortexed and sonicated for 10 min at
26°C in 4 ml of PBS using a Branson model 2510 sonicator (Branson
Ultrasonics Corporation, Danbury, Conn.), the water having been
previously degassed in the bath for 5 min.
Two sets of experiments were performed, each in duplicate, differing in
growth conditions by the presence or absence of a piece of PVC catheter
and means of subsequent inoculation. As shown in Table
1, at 24 h, in broth culture, both
C. albicans and C. dubliniensis were detected in
9 of 11 (82%) (range of C. dubliniensis detected, 8 to
35%) of the cultures and C. albicans alone was detected in
2 of 11 (18%). At 96 h, in broth culture, both species were
detected in only 2 of 11 (18%) (range of C. dubliniensis
detected, 37 to 42%) of the cultures and C. albicans alone
was detected in 9 of 11 (82%). In both instances in which mixed
culture was maintained, the same C. albicans isolate (1649) was used in the competition pairing. At 96 h, both species were detected in 5 of 11 (45%) (range of C. dubliniensis
detected, 1 to 52%) of the cultures from the PVC pieces, and C. albicans alone was detected in 6 of 11 (55%).
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Growth Competition between Candida
dubliniensis and Candida albicans under Broth and
Biofilm Growing Conditions
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
70°C and in sterile deionized H2O at room temperature.
TABLE 1.
Yeast isolate pairings and retention of C. dubliniensis after 24 and 96 h of growth competition
Log-phase doubling times were determined for each isolate of C. albicans and C. dubliniensis used in the growth assays. Yeast isolates were purified and subcultured as described above. Three to five colonies were then suspended in 5.0 ml of sterile deionized H2O and mixed thoroughly on a vortex mixer. The suspension was adjusted to a 0.5 McFarland turbidity standard (106 CFU/ml) using a spectrophotometer (22). Each isolate was inoculated at 106 CFU into 4 ml of SDB and incubated at 37°C with vigorous shaking. Absorbance readings (600 nm) were obtained at 2-h intervals for 8 h. Growth curves were generated using CA-CricketGraph III (Computer Associates, Islandia, N.Y.). Doubling times were obtained from portions of the curves corresponding to the logarithmic growth phase of each yeast.
Log-phase cell doubling times (± standard errors) for pure cultures of C. albicans averaged 2.0 ± 0.11 h (range, 1.7 to 2.6 h), while those for C. dubliniensis were 2.7 ± 0.16 h (range, 2.2 to 3.3 h) (P < 0.005). C. dubliniensis had a higher log-phase doubling rate in only one pair of isolates examined, isolate 1770 (C. dubliniensis) and 1649 (C. albicans). In all other combinations, the C. albicans isolate had the higher doubling rate.
Results of the planktonic growth competition between the two species in SDB showed that C. albicans had a competitive advantage, unrelated to MIC, over C. dubliniensis was undetectable in two sets of assays, while in the other nine sets of tubes, C. dubliniensis ranged from 8 to 35% of broth composition. At 96 h, the results were even more dramatic, with only 2 of 11 sets showing retention of C. dubliniensis. C. albicans had a higher log-phase cell doubling rate than did C. dubliniensis in 10 of 11 pairings. With the exception of one pairing involving C. albicans 1649, at 96 h, the slower-growing isolate was overwhelmed by the faster-growing isolate, as might be expected. These results support observations from bacterial studies that microorganisms in a well-mixed planktonic culture tend to display a single phenotype (9); thus, competitive pressures within suspension cultures may drive the development of a monoculture, allowing the retention of low levels of competitors. Under such uniform conditions, all cells have equal access to nutrients, dispersion of metabolic waste, temperature, and pH; therefore, those phenotypes or organisms with superior growth rates would be expected to dominate over time, as seen here at both 24 and 96 h.
Growth competition between the two species under conditions supportive of biofilm growth revealed that C. albicans again had a competitive advantage over C. dubliniensis at 96 h, apparently unrelated to MIC. C. dubliniensis was undetectable in 6 of 11 sets of assays yet was present at a concentration of 1 to 52% in the other 5 sets. Population variations due to differences in growth rate were less apparent under the biofilm growing conditions. Growth within a biofilm community tends to vary according to cellular spatial organization. Organisms near the nutrient source exhibit a different phenotype from that of organisms deep within the biofilm substratum (9). Such heterogeneity within the community may induce metabolic cooperation between its members (7), enhancing the survival of the biofilm and thereby encouraging the persistence of yeasts that, under planktonic conditions, might succumb to competitive pressure.
Little is known about interspecies interactions between C. albicans and C. dubliniensis, yet these species have been isolated concomitantly from the oral cavities of immunocompromised patients. In this series of experiments, equal numbers of CFU of C. albicans and C. dubliniensis were coinoculated into SDB and incubated under similar growing conditions, differing chiefly by the presence of a PVC substrate. Results of these growth competition studies showed that C. albicans had a distinct competitive advantage over C. dubliniensis. Under planktonic growth conditions, C. albicans demonstrated superior growth characteristics over C. dubliniensis; however, under biofilm growing conditions, with supporting structure afforded by PVC, C. dubliniensis was able to better withstand the rigorous competitive pressures from C. albicans.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from Pfizer Inc. and by Public Health Service grants 1R29 AI42401 (to J.L.L.-R.), 5 RO1 DE11381 (to T.F.P.), and M01-RR-01346 (for the Frederic C. Bartter General Clinical Research Center).
Chromogenic medium was provided by CHROMagar Company. We thank the Fungus Testing Laboratory at UTHSCSA for performing antifungal susceptibility testing.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The University of Texas Health Science Center at San Antonio, Department of Medicine, Division of Infectious Diseases, 7703 Floyd Curl Dr., San Antonio, TX 78284-7881. Phone: (210) 567-4823. Fax: (210) 567-4670. E-mail: KIRKPATRICK{at}UTHSCSA.EDU.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baillie, G. S., and L. J. Douglas.
1998.
Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.
Antimicrob. Agents Chemother.
42:1900-1905 |
| 2. |
Barchiesi, F.,
A. L. Colombo,
D. A. McGough, and M. G. Rinaldi.
1994.
Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
J. Clin. Microbiol.
32:2494-2500 |
| 3. | Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157[Abstract]. |
| 4. | Carlsson, J. 1997. Bacterial metabolism in dental biofilms. Adv. Dent. Res. 11:75-80[Abstract]. |
| 5. |
Chaffin, W. L.,
J. L. López-Ribot,
M. Casanova,
D. Gozalbo, and J. P. Martínez.
1998.
Cell wall and secreted proteins of Candida albicans: identification, function, and expression.
Microbiol. Mol. Biol. Rev.
62:130-180 |
| 6. | Challacombe, S. J. 1994. Immunological aspects of candidiasis. Med. Oral Pathol. 78:202-210. |
| 7. | Costerton, J. W., and Z. Lewandoski. 1997. The biofilm lifestyle. Adv. Dent. Res. 11:192-195. |
| 8. |
Espinel-Ingroff, A.,
C. W. Kish, Jr.,
T. M. Kerkering,
R. A. Fromtling,
K. Bartizal,
J. N. Galgiani,
K. Villareal,
M. A. Pfaller,
T. Gerarden,
M. G. Rinaldi, and A. Fothergill.
1992.
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.
J. Clin. Microbiol.
30:3138-3145 |
| 9. | Gilbert, P., J. Das, and I. Foley. 1997. Biofilm susceptibility to antimicrobials. Adv. Dent. Res. 11:160-167[Abstract]. |
| 10. | Gilfillian, G. D., D. J. Sullivan, K. Haynes, T. Parkinson, D. C. Coleman, and N. A. R. Gow. 1998. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144:829-838[Abstract]. |
| 11. | Hawser, S. 1996. Adhesion of different Candida spp. to plastic: XTT formazan determinations. J. Med. Vet. Mycol. 34:407-410[Medline]. |
| 12. |
Hawser, S. P., and L. J. Douglas.
1994.
Biofilm formation by Candida species on the surface of catheter materials in vitro.
Infect. Immun.
62:915-921 |
| 13. |
Kirkpatrick, W. R.,
S. G. Revankar,
R. K. McAtee,
J. L. Lopez-Ribot,
A. W. Fothergill,
D. I. McCarthy,
S. E. Sanche,
R. A. Cantu,
M. G. Rinaldi, and T. F. Patterson.
1998.
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates.
J. Clin. Microbiol.
36:3007-3012 |
| 14. |
Lopez-Ribot, J. L.,
R. K. McAtee,
L. N. Lee,
W. R. Kirkpatrick,
T. C. White,
D. Sanglard, and T. F. Patterson.
1998.
Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrob. Agents Chemother.
42:2932-2937 |
| 15. |
Marcotte, H., and M. C. Lavoie.
1998.
Oral microbial ecology and the role of salivary immunoglobulin A.
Microbiol. Mol. Biol. Rev.
62:71-109 |
| 16. |
Moran, G. P.,
D. Sanglard,
S. M. Donnelly,
D. B. Shanley,
D. J. Sullivan, and D. C. Coleman.
1998.
Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
Antimicrob. Agents Chemother.
42:1819-1830 |
| 17. | Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623[Abstract]. |
| 18. | National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 19. | Nikawa, H., H. Nishimura, T. Hamada, H. Kumagi, and L. P. Samaranayake. 1997. Effects of dietary sugars and, saliva and serum on Candida biofilm formation on acrylic surfaces. Mycopathologia 139:87-91[CrossRef][Medline]. |
| 20. | Panagoda, G. J., A. N. B. Ellepola, and L. P. Samaranayake. 1998. Adhesion to denture acrylic surfaces and relative cell-surface hydrophobicity of Candida parapsilosis and Candida albicans. APMIS 106:736-742[Medline]. |
| 21. | Patterson, T. F., S. G. Revankar, W. R. Kirkpatrick, O. Dib, A. W. Fothergill, S. W. Redding, D. A. Sutton, and M. G. Rinaldi. 1996. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J. Clin. Microbiol. 34:1794-1797[Abstract]. |
| 22. |
Pfaller, M. A.,
L. Burmeister,
M. S. Bartlett, and M. G. Rinaldi.
1988.
Multicenter evaluation of four methods of yeast inoculum preparation.
J. Clin. Microbiol.
26:1437-1441 |
| 23. | Revankar, S. G., O. P. Dib, W. R. Kirkpatrick, R. K. McAtee, A. W. Fothergill, M. G. Rinaldi, S. W. Redding, and T. F. Patterson. 1997. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 26:960-963. |
| 24. | Revankar, S. G., W. R. Kirkpatrick, R. K. McAtee, O. P. Dib, A. W. Fothergill, S. W. Redding, D. A. McGough, M. G. Rinaldi, and T. F. Patterson. 1996. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in HIV-infected patients. J. Infect. Dis. 174:821-827[Medline]. |
| 25. | Samaranayake, Y. H., P. C. Wu, L. P. Samaranayake, and M. So. 1995. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS 103:707-713[Medline]. |
| 26. | Schoofs, A., F. C. Odds, R. Colebunders, M. Leven, and H. Goosens. 1997. Use of specialized isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:296-300[CrossRef][Medline]. |
| 27. |
Sullivan, D., and D. Coleman.
1998.
Candida dubliniensis: characteristics and identification.
J. Clin. Microbiol.
36:329-334 |
| 28. | Sullivan, D., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964[Abstract]. |
| 29. | Sullivan, D. J., M. C. Henman, G. P. Moran, L. C. O'Neill, D. E. Bennett, D. B. Shanley, and D. C. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408[Abstract]. |
| 30. | Webb, B. C., C. J. Thomas, M. D. P. Willcox, D. W. S. Harty, and K. W. Knox. 1998. Candida-associated denture stomatitia. Aetiology and management: a review. Aust. Dent. J. 43:45-50[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|